Jeff Yass’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.1K Sell
18,400
-107,300
-85% -$173K ﹤0.01% 13105
2026
Q2
$245K Sell
125,700
-78,400
-38% -$160K ﹤0.01% 11511
2026
Q1
$492K Sell
204,100
-14,600
-7% -$32.6K ﹤0.01% 9707
2025
Q4
$437K Sell
218,700
-74,600
-25% -$177K ﹤0.01% 9120
2025
Q3
$895K Buy
293,300
+263,300
+878% +$821K ﹤0.01% 7605
2025
Q2
$75.6K Buy
30,000
+2,800
+10% +$6.7K ﹤0.01% 11942
2025
Q1
$41.1K Buy
+27,200
New +$48.1K ﹤0.01% 11922

Other funds holding MBOT

Jeff Yass's MBOT Position: Q3 2026 in Review

Jeff Yass increased its Microbot Medical (MBOT) stake by 2.5% in Q3 2026, buying an estimated $21.3K and bringing the position to 539,047 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #9058.

Jeff Yass first reported a position in MBOT in Q3 2014 and has held it in 12 quarters since. The position peaked at $3.81M in Q3 2025. 73 funds tracked by Wall St. Rank hold MBOT as of Q3 2026.

  • Jeff Yass held 539,047 shares of Microbot Medical worth $647K as of Q3 2026.
  • Jeff Yass bought 13,220 Microbot Medical shares in Q3 2026, an estimated $21.3K.
  • Microbot Medical made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #9058 holding.
  • Jeff Yass first reported a position in Microbot Medical in Q3 2014 and has held it in 12 quarters since.
  • Jeff Yass's Microbot Medical position peaked at $3.81M in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Microbot Medical as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.